Astal Laboratories Reports Zero Deviation in Fund Utilization for September 2026 Quarter
Astal Laboratories Ltd 路 Others (Uncategorized) 路 14 Nov 2026, 1:37 am
Astal Laboratories Reports Zero Deviation in Fund Utilization for September 2026 Quarter Astal Laboratories reported nil deviation or variation in the utilization of funds raised for the quarter ended 30th Sep'26, following review by its Audit Committee and Board on 13th Nov'26. The company fully utilized the total proceeds of Rs 33.99 Lakhs raised on 25th May'26 toward its designated long-term objectives, encompassing capital expenditure, working capital, and general corporate purposes to support ongoing business growth.
Original exchange filing (PDF)
More announcements from Astal Laboratories Ltd
- Submission of Financial Results. 路 14 Nov 2026
- Submission of outcome of the board meeting. 路 14 Nov 2026
- Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve the unaudited standalone .... 路 13 Nov 2026
- Submission of Voting Results. 路 01 Oct 2026
- Submission of voting Results with scrutinizers report. 路 01 Oct 2026
- Attached. 路 30 Sept 2026
- Attached 路 30 Sept 2026
- Submission of outcome of 33rd Annual General Meeting. 路 29 Sept 2026
